STOCK TITAN

Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Medical Care Technologies (OTCID:MDCE) has paused equity issuance and plans to reassess its expansion plans and funding in 2027.

In its unaudited results for the quarter ended September 30, 2026, sales revenue rose 13% to $538,981, gross profit rose 55% to $240,839, and net operating income rose 254% to $192,565. Net income rose 270% to $192,565. Nine-month net income was $198,883 versus a net loss of $145,347 a year earlier, and gross profit rose to $332,744. Quarter-end cash was $102,172, with no current liabilities.

Infinite Auctions’ Q4 private sales surpassed $300,000. Development continues under MDCE’s first paid external software agreement, valued at up to $250,000, and the first payment has been initiated. Its subsidiaries manage approximately $20 million in private collectibles assets, with potential net profits dependent on completed sales.

Loading...
Loading translation...
13 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate point. Forward-looking: it has not happened yet and may not happen.Equity issuance is paused, with expansion plans and funding to be reassessed in 2027
  • Moderate pointQ3 net income rose 270% to $192,565
  • Moderate pointQ3 sales revenue rose 13% to $538,981
  • Moderate pointQ3 gross profit rose 55% to $240,839
  • Moderate pointInfinite Auctions’ Q4 private sales have surpassed $300,000
  • Moderate pointFirst paid external software agreement is valued at up to $250,000, with development underway
7 minor points
  • Minor pointQ3 net operating income rose 254% to $192,565
  • Minor pointNine-month net income reached $198,883 versus a net loss of $145,347 a year earlier
  • Minor pointNine-month gross profit rose to $332,744
  • Minor pointFirst payment under the software agreement has been initiated
  • Minor pointInfinite Auctions’ collectibles partnership has already generated six-figure transaction activity
  • Minor pointReal Game Used continues to maintain a backlog of customer and auction-brand authentication work
  • Minor pointCurrent liabilities were zero at quarter-end

Negative

  • Minor point. Forward-looking: it has not happened yet and may not happen.Potential net profits on approximately $20 million in managed private collectibles assets depend on completed sales

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MESA, AZ / ACCESS Newswire / November 19, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that it has paused dilution and does not currently plan to resume equity issuance until 2027 when expansion plans and funding are to be re-evaluated in efforts to align with shareholder value and continuing near term revenue. The decision follows the Company's third-quarter results showing a sharp improvement in profitability and accelerating private sales activity at its Infinite Auctions subsidiary.

On November 12, MDCE reported unaudited results for the three and nine months ended September 30, 2026. Third-quarter sales revenue rose 13% to $538,981. Gross profit increased 55% to $240,839. Net operating income rose 254% to $192,565, and net income increased 270% to $192,565. For the nine-month period, the Company reported net income of $198,883 compared to a net loss of $145,347 in the prior-year period. Gross profit rose to $332,744. The Company ended the quarter with zero current liabilities and cash of $102,172.

Supporting the decision to pause dilution is revenue generation at Infinite Auctions. Private sales at the subsidiary have already surpassed $300,000 in the fourth quarter. This activity builds on the subsidiary's partnership with a multi-billion-dollar sports card and collectibles company, under which six-figure transaction activity has already occurred. Real Game Used continues to maintain a continuous backlog of customer and auction-brand authentication work through its automated submission system. The Company has also announced that its subsidiaries are managing approximately $20 million in private collectibles assets, with potential net profits contingent on completed sales.

In parallel, technical development continues under MDCE's first paid external software agreement, valued at up to $250,000, covering an integrated web and enterprise platform for inventory and sales workflows. The first payment under that agreement has been initiated. StrainScan Pro enterprise demonstrations remain active. Internal evaluation continues on MDCE Melanoma Scan Beta and the wound-monitoring application, with updated technical results available on the Company's corporate website.

"Shareholders have expressed concern about dilution and this is our response," said Marshall Perkins, CEO of Medical Care Technologies. "The third-quarter results showed net income up 270% and a clear improvement in profitability. Infinite Auctions private sales have already surpassed $300,000 in Q4. That revenue, together with the software agreement now in active development and the ongoing work at our subsidiaries, gives us the ability to pause further equity issuance through 2027. The focus is on building from the commercial activity we already have in motion."

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company owns subsidiaries Infinite Auctions and Real Game Used. Visit: medicalcaretechnologies.com | infiniteauctions.com | realgameused.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and projections about the Company's business and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Such risks include the Company's ability to continue generating revenue from subsidiaries and software activities, complete development under existing agreements, sustain private sales activity, and manage its capital structure. Any decision to pause or resume equity issuance is subject to change based on operating results, capital needs, and other factors. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law. Investors are cautioned not to place undue reliance on these forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Website: medicalcaretechnologies.com

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Has Medical Care Technologies (MDCE) paused equity issuance?

Medical Care Technologies has paused equity issuance and plans to reevaluate its expansion plans and funding in 2027.

How much has MDCE’s Infinite Auctions generated in Q4 private sales?

Infinite Auctions has recorded more than $300,000 in Q4 private sales.

What will Medical Care Technologies build under its first paid external software agreement?

The agreement covers an integrated web and enterprise platform for managing inventory and sales workflows.

Keep reading